A murine model is proposed for evaluating potential therapeutic agents for alcohol abuse as to their efficacy in reducing ethanol consumption and altering its interoceptive effects. The proposed experiments will utilize C57BL/6 mice, recognized for their consumption of ethanol, to assess ethanol consumption in a limited access paradigm and its interoceptive effect utilizing an operant ethanol discrimination paradigm after treatment with three antagonists; naltrexone, broad spectrum opioid receptor antagonist; naltrindole, a relatively specific delta-opioid receptor antagonist; and MDL 72222, a relatively specific 5-HT3 receptor antagonist. The following hypotheses and related specific aims will be examined. HYPOTHESIS 1 is that broad spectrum opioid, delta-opioid, and 5-HT3 antagonists will reduce ethanol consumption and its interoceptive effects. Thus, Specific Aim 1 is to determine the dose-responsive effects of naltrexone, naltrindole, and MDL 72222 on ethanol consumption and discrimination. These experiments will include time course evaluations to insure optimal intervals between antagonist injection and ethanol test, and sufficient doses to estimate ED50s for each antagonist. HYPOTHESIS 2 is that opioid and 5-HT receptor antagonists will act synergistically to reduce the consumption of ethanol and its interoceptive effect.
Thus Specific Aim 2 is to compare the effects of naltexone + MDL 7222 and naltrindole + MDL 72222 combinations on ethanol consumption and discrimination with effects of each alone. Doses in the experiments will be selected to allow isobolographic evaluation for drug additivity and potentiation. HYPOTHESIS 3 is that withdrawal from chronic ethanol consumption will alter its interoceptive effects and that the alteration will be attenuated by opioid- and 5-HT3- antagonists.
Specific Aim 3 is thus to determine if withdrawal from chronic ethanol exposure alters its discriminability and if such alterations can be counter-acted by naltrexone, naltrindole, or MDL 72222. The experiment involves training mice to discriminate ethanol and then a comparing groups of chronic- ethanol-exposed mice with controls on ethanol discrimination either in the presence or absence of antagonist. Finally, HYPOTHESIS 4 is that withdrawal from chronic exposure to opioid- and 5-HT3- antagonists will alter the interoceptive effects of ethanol.
Specific Aim 4 is to determine if ethanol discrimination will be altered during withdrawal from chronic naltrexone, naltrindole, and MDL 72222. The experiment involves training mice to discriminate ethanol and then comparing groups chronically treated with vehicle or one of the antagonists during a re-test and reacquisition of the ethanol discrimination.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Specialized Center (P50)
Project #
5P50AA010761-04
Application #
6097728
Study Section
Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Haun, Harold L; Griffin, William C; Lopez, Marcelo F et al. (2018) Increasing Brain-Derived Neurotrophic Factor (BDNF) in medial prefrontal cortex selectively reduces excessive drinking in ethanol dependent mice. Neuropharmacology 140:35-42
Schacht, Joseph P; Voronin, Konstantin E; Randall, Patrick K et al. (2018) Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial. Neuropsychopharmacology 43:1247-1256
McGuier, Natalie S; Rinker, Jennifer A; Cannady, Reginald et al. (2018) Identification and validation of midbrain Kcnq4 regulation of heavy alcohol consumption in rodents. Neuropharmacology 138:10-19
Nimitvilai, Sudarat; Lopez, Marcelo F; Woodward, John J (2018) Effects of monoamines on the intrinsic excitability of lateral orbitofrontal cortex neurons in alcohol-dependent and non-dependent female mice. Neuropharmacology 137:1-12
Dowdle, Logan T; Brown, Truman R; George, Mark S et al. (2018) Single pulse TMS to the DLPFC, compared to a matched sham control, induces a direct, causal increase in caudate, cingulate, and thalamic BOLD signal. Brain Stimul 11:789-796
Zamudio-Bulcock, Paula A; Homanics, Gregg E; Woodward, John J (2018) Loss of Ethanol Inhibition of N-Methyl-D-Aspartate Receptor-Mediated Currents and Plasticity of Cerebellar Synapses in Mice Expressing the GluN1(F639A) Subunit. Alcohol Clin Exp Res 42:698-705
Cannady, Reginald; Rinker, Jennifer A; Nimitvilai, Sudarat et al. (2018) Chronic Alcohol, Intrinsic Excitability, and Potassium Channels: Neuroadaptations and Drinking Behavior. Handb Exp Pharmacol 248:311
Harlan, Benjamin A; Becker, Howard C; Woodward, John J et al. (2018) Opposing actions of CRF-R1 and CB1 receptors on VTA-GABAergic plasticity following chronic exposure to ethanol. Neuropsychopharmacology 43:2064-2074
Hanlon, Colleen A; Dowdle, Logan T; Henderson, J Scott (2018) Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development. Pharmacol Rev 70:661-683
Hanlon, Colleen A; Dowdle, Logan T; Gibson, Nicole B et al. (2018) Cortical substrates of cue-reactivity in multiple substance dependent populations: transdiagnostic relevance of the medial prefrontal cortex. Transl Psychiatry 8:186

Showing the most recent 10 out of 209 publications